Ya agreed. Oncs still has a lot more than many developing biotechs. The pps is a function of the management. Punit should not be ceo. We need someone like kim from ino. A real dr. I doubt punit even.understands the science.
I'm .55 at ~20,000 shares. At some point we can expect oncs to recover, but when? The next catalyst isn't for 6 months, right?
What is Punit doing? Have you guys seen the FB? Random pieces on cancer research. And they are still collecting enormous salaries. There are stocks with half of ONCSs specs and are trading far better.
I can see .20 or even lower next month unless ONCS gives up something, anything.